Good Pharma Scorecard

We rank companies on ethics and social responsibility performance criteria, focusing on issues that are critical to patients and public health.

The Good Pharma Scorecard ranks companies on their bioethics and social responsibility performance and governance, taking into account ethics and legal standards. Measures evaluate the integrity of clinical trial designs, the accessibility of medicines, marketing practices, diversity and fair inclusion, among other ethics and human rights issues. Below is a sample of our company and product rankings.

What we measure

Transparency and data-sharing practices

Clinical trial design integrity

Diversity, equity and fair inclusion in research and the workplace

Accessibility of medicines, vaccines and devices

Fair benefit-sharing

Marketing practices

Drug
Sponsor/Co-Sponsor
Indication
Drug
Sponsor/
Co-Sponsor
Indication
Transparency
Score
# 1 Cabozantinib Exelixis Thyroid cancer
Exelixis
Thyroid cancer
# 1 Dinutuximab United Therapeutics Neuroblastoma
United Therapeutics
Neuroblastoma
# 1 Elotuzumab Bristol-Myers Squibb Multiple Myeloma
Bristol-Myers Squibb
Multiple Myeloma
# 1 Enasidenib Bristol-Myers Squibb Leukemia
Bristol-Myers Squibb
Leukemia
# 1 Enzalutamide Pfizer Prostate Cancer
Pfizer
Prostate Cancer
# 1 Ibrutinib AbbVie Mantle Cell Lymphoma
AbbVie
Mantle Cell Lymphoma
# 1 Inotuzumab Pfizer Leukemia
Pfizer
Leukemia
# 1 Ixazomib Takeda Multiple Myeloma
Takeda
Multiple Myeloma
# 1 Lenvatinib Eisai Thyroid Cancer
Eisai
Thyroid Cancer
# 1 Neratinib Puma Breast Cancer
Puma
Breast Cancer
# 1 Radium-223 Dichloride Bayer Prostate Cancer
Bayer
Prostate Cancer
# 1 Ribociclib Novartis Breast Cancer
Novartis
Breast Cancer
# 1 Sonidegib Novartis Basal Cell Carcinoma
Novartis
Basal Cell Carcinoma
# 1 Ziv-Aflibercept Sanofi Colorectal Cancer
Sanofi
Colorectal Cancer
# 15 Abemaciclib Eli Lilly Breast Cancer
Eli Lilly
Breast Cancer
# 16 Atezolizumab Roche Urothelial Cancer
Roche
Urothelial Cancer
# 16 Carfilzomib Amgen Multiple Myeloma
Amgen
Multiple Myeloma
# 16 Niraparib GlaxoSmithKline Ovarian Cancer
GlaxoSmithKline
Ovarian Cancer
# 16 Nivolumab Bristol-Myers Squibb Melanoma
Bristol-Myers Squibb
Melanoma
# 16 Olaratumab Eli Lilly Soft Tissue Sarcoma
Eli Lilly
Soft Tissue Sarcoma
# 16 Trifluridine and Tipiracil Otsuka Colorectal Cancer
Otsuka
Colorectal Cancer
# 22 Avelumab Merck Merkel Cell Carcinoma
Merck
Merkel Cell Carcinoma
# 22 Axitinib Pfizer Renal Cell Carcinoma
Pfizer
Renal Cell Carcinoma
# 22 Daratumumab Johnson & Johnson Multiple Myeloma
Johnson & Johnson
Multiple Myeloma
# 22 Panobinostat Novartis Multiple Myeloma
Novartis
Multiple Myeloma
# 22 Ponatinib Takeda CML
Takeda
CML
# 27 Cobmetinib Roche / Genentech Melanoma
Roche / Genentech
Melanoma
# 27 Trabectedin Johnson & Johnson / Janssen Liposarcoma
Johnson & Johnson / Janssen
Liposarcoma
# 29 Axicabtagene Ciloleucel Gilead Non-Hodgkin Lymphoma
Gilead
Non-Hodgkin Lymphoma
# 29 Trametinib GlaxoSmithKline Metastatic Melanoma
GlaxoSmithKline
Metastatic Melanoma
80% Median Median score

Median: 80%

# 31 Osimertinib AstraZeneca Lung Cancer
AstraZeneca
Lung Cancer
# 32 Bosutinib Pfizer CML
Pfizer
CML
# 32 Obinutuzumab Roche CLL
Roche
CLL
# 32 Olaparib AstraZeneca Ovarian Cancer
AstraZeneca
Ovarian Cancer
# 32 Palbociclib Pfizer Breast Cancer
Pfizer
Breast Cancer
# 32 Pertuzumab Roche Breast Cancer
Roche
Breast Cancer
# 32 Pomalidomide Bristol-Myers Squibb Multiple Myeloma
Bristol-Myers Squibb
Multiple Myeloma
# 32 Trastuzumab Emtansine Roche Breast Cancer
Roche
Breast Cancer
# 32 Venetoclax Abbvie Chronic Lymphocytic Leukemia
Abbvie
Chronic Lymphocytic Leukemia
# 40 Blintumomab Amgen B-cell ALL
Amgen
B-cell ALL
# 40 Ceritinib Novartis Lung Cancer
Novartis
Lung Cancer
# 42 Alectinib Roche Lung Cancer
Roche
Lung Cancer
# 42 Durvalumab AstraZeneca Urothelial Cancer
AstraZeneca
Urothelial Cancer
# 44 Acalabrutinib AstraZeneca Non-Hodgkin Lymphoma
AstraZeneca
Non-Hodgkin Lymphoma
# 45 Afatinib Boehringer Ingelheim Lung Cancer
Boehringer Ingelheim
Lung Cancer
# 45 Belinostat Spectrum T-cell Lymphoma
Spectrum
T-cell Lymphoma
# 45 Brigatinib Takeda Lung Cancer
Takeda
Lung Cancer
# 45 Dabrafenib GlaxoSmithKline Metastatic Melanoma
GlaxoSmithKline
Metastatic Melanoma
# 45 Idelalisib Gilead Non-Hodgkin Lymphoma
Gilead
Non-Hodgkin Lymphoma
# 45 Necitumumab Eli Lilly Lung Cancer
Eli Lilly
Lung Cancer
# 45 Omacetaxine Mepesuccinate Teva CML
Teva
CML
# 45 Pembrolizumab Merck Melanoma
Merck
Melanoma
# 45 Ramucirumab Eli Lilly Gastric cancer
Eli Lilly
Gastric cancer
# 45 Rucaparib Clovis Oncology Ovarian Cancer
Clovis Oncology
Ovarian Cancer
# 45 Tisagenlecleucel Novartis ALL
Novartis
ALL
# 45 Vismodegib Roche Basal Cell Carcinoma
Roche
Basal Cell Carcinoma
# 57 Midostaurin Novartis AML
Novartis
AML
# 58 Copanlisib Bayer Non-Hodgkin Lymphoma
Bayer
Non-Hodgkin Lymphoma
# 58 Regorafenib Bayer Colorectal cancer
Bayer
Colorectal cancer